EpCAM is proposed as a marker for detecting CTCs, given that it is rarely expressed on the surface of leukocytes but highly expressed in the majority of epithelium-derived cancers, such as BC, HCC and colorectal cancer (Fig. 3b) [104]. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.